DLBCL arising from indolent lymphomas: How are they different?

Semin Hematol. 2023 Nov;60(5):277-284. doi: 10.1053/j.seminhematol.2023.11.002. Epub 2023 Nov 23.

Abstract

Transformation to diffuse large B-cell lymphoma (DLBCL) is a recognized, but unpredictable, clinical inflection point in the natural history of indolent lymphomas. Large retrospective studies highlight a wide variability in the incidence of transformation across the indolent lymphomas and the adverse outcomes associated with transformed lymphomas. Opportunities to dissect the biology of transformed indolent lymphomas have arisen with evolving technologies and unique tissue collections enabling a growing appreciation, particularly, of their genetic basis, how they relate to the preceding indolent lymphomas and the comparative biology with de novo DLBCL. This review summarizes our current understanding of both the clinical and biological aspects of transformed lymphomas and the outstanding questions that remain.

Keywords: CLL; Diffuse large B-cell lymphoma; Follicular lymphoma; Marginal zone lymphoma; Transformation; Waldenström macroglobulinemia.

Publication types

  • Review

MeSH terms

  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Lymphoma, Non-Hodgkin* / genetics
  • Lymphoma, Non-Hodgkin* / pathology
  • Neoplasm Recurrence, Local
  • Retrospective Studies